92: [177Lu]Lu-Dota-Tate as First-Line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS): The NETTER-2 Study. (September 2022)

Record Type:
Journal Article
Title:
92: [177Lu]Lu-Dota-Tate as First-Line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS): The NETTER-2 Study. (September 2022)
Main Title:
92: [177Lu]Lu-Dota-Tate as First-Line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS): The NETTER-2 Study
Authors:
Myrehaug, Sten
Singh, Simron
Pavel, Marianne
Kunz, Pamela
de Herder, Wouter
Herrmann, Ken
D'Amelio, Anthony
Santoro, Paola
Folitar, Ilya
Ferone, Diego
Abstract:
Is Part Of:
Radiotherapy and oncology. Volume 174(2022)Supplement 1
Journal:
Radiotherapy and oncology
Issue:
Volume 174(2022)Supplement 1
Issue Display:
Volume 174, Issue 1 (2022)
Year:
2022
Volume:
174
Issue:
1
Issue Sort Value:
2022-0174-0001-0000
Page Start:
S40
Page End:
S41
Publication Date:
2022-09
Subjects:
Oncology -- Periodicals
Radiotherapy -- Periodicals
Tumors -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- radiotherapy -- Periodicals
Radiotherapy -- Periodicals
Radiothérapie -- Périodiques
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9940642
Journal URLs:
http://www.sciencedirect.com/science/journal/01678140 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01678140 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01678140 ↗
http://www.estro.org/ ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/radiotherapy-and-oncology/ ↗
DOI:
10.1016/S0167-8140(22)04371-7 ↗
Languages:
English
ISSNs:
0167-8140
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 7240.790000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
23950.xml